Skip to main content

TEVA 8199 TEVA 8199 Pill - maroon capsule/oblong, 14mm

Pill with imprint TEVA 8199 TEVA 8199 is Maroon, Capsule/Oblong and has been identified as Sunitinib Malate 12.5 mg. It is supplied by Teva Pharmaceuticals USA, Inc.

Sunitinib is used in the treatment of Renal Cell Carcinoma; Gastrointestinal Stromal Tumor; Pancreatic Cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sunitinib 12.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 8199 TEVA 8199

Sunitinib malate 12.5 mg TEVA 8199 TEVA 8199

Sunitinib Malate

TEVA 8199 TEVA 8199
12.5 mg
14.00 mm
Prescription only
Drug Class
Multikinase inhibitors, VEGF/VEGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
Inactive Ingredients
croscarmellose sodium, magnesium stearate, mannitol, povidone k30, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40, gelatin, titanium dioxide, ferrosoferric oxide, D&C Yellow No. 10 Aluminium Lake, FD&C Blue No. 1 Aluminium Lake, FD&C Blue No. 2 Aluminium Lake, shellac, propylene glycol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.